Odisha News, Odisha Latest news, Odisha Daily - OrissaPOST
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
No Result
View All Result
OrissaPOST - Odisha Latest news, English Daily -
No Result
View All Result

Fight against COVID-19: Odisha receives first consignment of Remdesivir and Favipiravir medicines

PNN & Agencies
Updated: June 29th, 2020, 17:58 IST
in Coronavirus, Metro, Top Stories
0
Fight against COVID-19: Odisha receives first consignment of Remdesivir and Favipiravir

Photo courtesy: The Wire

Share on FacebookShare on TwitterShare on WhatsAppShare on Linkedin

Bhubaneswar: The Odisha government received Monday the first consignment of ‘Remdesivir’ and ‘Favipiravir’ medicines for treatment of COVID-19 patients.

Additional Chief Secretary (ACS), Health and Family Welfare Department, PK Mohapatra said Remdesivir medicine will be used only in the treatment of moderate to severely ill COVID-19 patients.

Also Read

Court order

Man gets life sentence for sexually assaulting blind minor

8 hours ago
Himanshu Kumar Lal

Odisha police launch campaign after back-to-back student su*cides

8 hours ago

“The Remdesivir medicines have been sent to all COVID-19 hospitals across Odisha,” informed Mohapatra. “The drugs will help reduce fatality rate (which is 0.39 per cent in Odisha). It is a nucleoside analogue pro-drug having inhibitory effects on pathogenic animal and human coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro,” he added.

The ACS Health and Family Welfare said it inhibits Middle East respiratory syndrome coronavirus, SARS-CoV-1, and SARS-CoV-2 replication in animal models. “It (Remdesivir) is administered via injection into a vein of the patient,” informed Mohapatra.

Meanwhile, Odisha Drugs Controller Mamina Patnaik said, the state has also received 1,200 strips (each strip containing 34 tablets) of Fabi Flu (Favipiravir) tablets to cure patients with mild to moderate coronavirus.

“We will first send these tablets to COVID-19 hospitals for immediate use of the patients as a small consignment has so far been received,” said Patnaik. “The tablets will eventually be available for purchase in the market after they are received in larger numbers in subsequent phases,” she added.

“ This apart the state presently has a stock of two lakh tablets and two lakh injections of ‘Dexamethasone’.

Dexamethasone is used to treat conditions such as arthritis, blood/hormone/immune system disorders, allergic reactions, certain skin and eye conditions, breathing problems, certain bowel disorders, and certain cancers.

Mohapatra also rejected the possibility of Odisha facing a Delhi like situation in terms of hospital beds and ICU required for the COVID-19 patients. “Presently we have less than 1,900 patients while arrangement is in place for 22,340 isolation beds and 440 ICU beds,” he informed.

Mohapatra said this is not that only new cases are being detected every day, a large number of patients are also discharged after their recovery from the disease on a daily basis. He said the overall COVID bed occupancy remained within 25 per cent.

“Maximum number of patients requiring ventilators at any point of time in the state so far has been nine. Odisha already has 400 ventilators and another 100 will be procured soon.

 

 

 

Tags: COVID-19FavipiravirICUMedicinePK MohapatraRemdesivirVentilator
ShareTweetSendShare
Suggest A Correction

Enter your email to get our daily news in your inbox.

 

OrissaPOST epaper Sunday POST OrissaPOST epaper

Click Here: Plastic Free Odisha

#MyPaperBagChallenge

Sarmistha Nayak

December 12, 2019
#MyPaperBagChallenge

Archit Mohapatra

December 12, 2019
#MyPaperBagChallenge

D Rama Rao

December 12, 2019
#MyPaperBagChallenge

Keshab Chandra Rout

December 12, 2019
#MyPaperBagChallenge

Manas Samanta

December 12, 2019
#MyPaperBagChallenge

Ramakanta Sahoo

December 12, 2019
#MyPaperBagChallenge

Spinoj Pattnaik

December 12, 2019
#MyPaperBagChallenge

Surya Sidhant Rath

December 12, 2019
#MyPaperBagChallenge

Sipra Mishra

December 12, 2019
#MyPaperBagChallenge

Subhajyoti Mohanty

December 12, 2019
#MyPaperBagChallenge

Lopali Pattnaik

December 12, 2019
#MyPaperBagChallenge

Mrutyunjaya Behera

December 12, 2019
#MyPaperBagChallenge

Jhili Jena

December 12, 2019
#MyPaperBagChallenge

Geetanjali Patro

December 12, 2019
#MyPaperBagChallenge

Faiza Firdous

December 12, 2019
#MyPaperBagChallenge

Akriti Negi

December 12, 2019
#MyPaperBagChallenge

Narendra Kumar

December 12, 2019
#MyPaperBagChallenge

Adrita Bhattacharya

December 12, 2019
#MyPaperBagChallenge

Bijswajit Pradhan

December 12, 2019
#MyPaperBagChallenge

Adweeti Bhattacharya

December 12, 2019
#MyPaperBagChallenge

Priyasha Pradhan

December 12, 2019
#MyPaperBagChallenge

Parbati Mohanty

December 12, 2019
#MyPaperBagChallenge

Ipsita

December 12, 2019
#MyPaperBagChallenge

Nishikant Rout

December 12, 2019
#MyPaperBagChallenge

Rajashree Manasa Mohanty

December 12, 2019
#MyPaperBagChallenge

Arya Ayushman

December 12, 2019
#MyPaperBagChallenge

Pratik Kumar

December 12, 2019
#MyPaperBagChallenge

Praptimayee Biswal

December 12, 2019
#MyPaperBagChallenge

Sibarama Khotei

December 12, 2019
#MyPaperBagChallenge

Anshuman Sahoo

December 12, 2019

Archives

Editorial

Tariff Tactic

Tariff
August 13, 2025

The effects of US President Donald Trump’s imposition of a 50 per cent tariff on Indian goods have started to...

Read moreDetails

Conscious Capitalism

Conscious Capitalism
August 12, 2025

Companies have long justified sustainability initiatives as a way to boost their reputation, comply with external and internal standards, or...

Read moreDetails

Perpetual War

Benjamin Netanyahu
August 11, 2025

Almost two years into the war in Gaza, the Israeli security cabinet has approved yet another military escalation — a...

Read moreDetails

Strategic Blunder

Aakar Patel
August 10, 2025

In February 2018 the Trump White House drew up the ‘US strategic framework for the Indo-Pacific’. This paper, declassified in...

Read moreDetails
  • Home
  • State
  • Metro
  • National
  • International
  • Business
  • Editorial
  • Opinion
  • Sports
  • About Us
  • Advertise
  • Contact Us
  • Jobs
Developed By Ratna Technology

© 2024 All rights Reserved by OrissaPOST

  • News in Odia
  • Orissa POST Epaper
  • Video
  • Home
  • Trending
  • Metro
  • State
  • Odisha Special
  • National
  • International
  • Sports
  • Business
  • Editorial
  • Entertainment
  • Horoscope
  • Careers
  • Feature
  • Today’s Pic
  • Opinion
  • Sci-Tech
  • About Us
  • Contact Us
  • Jobs

© 2024 All rights Reserved by OrissaPOST

    • News in Odia
    • Orissa POST Epaper
    • Video
    • Home
    • Trending
    • Metro
    • State
    • Odisha Special
    • National
    • International
    • Sports
    • Business
    • Editorial
    • Entertainment
    • Horoscope
    • Careers
    • Feature
    • Today’s Pic
    • Opinion
    • Sci-Tech
    • About Us
    • Contact Us
    • Jobs

    © 2024 All rights Reserved by OrissaPOST